Breo Ellipta is a Respiratory (inhalation) Powder in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Fluticasone Furoate; Vilanterol Trifenatate.
| Product ID | 70518-2028_86bfbbaa-9de6-2805-e053-2991aa0a8c58 |
| NDC | 70518-2028 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Breo Ellipta |
| Generic Name | Fluticasone Furoate And Vilanterol Trifenatate |
| Dosage Form | Powder |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2019-04-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204275 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE |
| Active Ingredient Strength | 100 ug/1; ug/1 |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-04-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204275 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-04-17 |
| Ingredient | Strength |
|---|---|
| FLUTICASONE FUROATE | 100 ug/1 |
| SPL SET ID: | 37bfbe82-e68e-44d3-98f1-e9f71eb92fc9 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0173-0859 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate |
| 0173-0882 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate |
| 50090-2404 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate |
| 70518-2028 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BREO ELLIPTA 85826011 4502969 Live/Registered |
Glaxo Group Limited 2013-01-17 |